Forian Inc - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance

More Details of Forian Inc Company

Forian Inc. is a technology solutions company. The Company provides a suite of data management capabilities and data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments. Its operations consist of providing analytic and information services to the healthcare and related industries, which are all subscription and services-based solutions. Its offerings include commercial, Real World Evidence (RWE) and market access solutions and data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company provides its information solutions both as an enabling technology to consultants and service providers serving the healthcare and life sciences industries, as well as to end users in the healthcare and life sciences industries. It also offers machine learning applications for the financial services community.

Forian Inc Info



Ticker SymbolFORA

Company nameForian Inc

IPO dateMar 03, 2021

CEOMr. Max Wygod

Number of employees1

Security typeOrdinary Share

Fiscal year-endMar 03

Address41 University Drive

CityNEWTOWN

Stock exchangeThe Toronto Stock Exchange

CountryUnited States of America

Postal code18940

Phone12677578707

Websitehttps://forian.com/

Ticker SymbolFORA

IPO dateMar 03, 2021

CEOMr. Max Wygod

Company Executives of Forian Inc



Name

Name/Position

Position

Shareholding

Change

Mr. Shahir Kassam-Adams

Independent Director

174.93K

--

Dr. Mark J. Adler, M.D.

Independent Director

36.33K

+3.56%

Ms. Jennifer Hajj

Independent Director

10.00K

+14.29%

Ms. Alyssa F. Varadhan

Independent Director

5.00K

+33.33%

Mr. Max Wygod

Executive Chairman of the Board, President, Chief Executive Officer

--

Mr. Michael T. (Mike) Vesey

Chief Financial Officer

--

Mr. Adam Dublin

Chief Strategy Officer, Director

--

Mr. Ian G. Banwell

Independent Director

--

Dr. Kristiina S. Vuori, M.D., Ph.D.

Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. Shahir Kassam-Adams

Independent Director

174.93K

--

Dr. Mark J. Adler, M.D.

Independent Director

36.33K

+3.56%

Ms. Jennifer Hajj

Independent Director

10.00K

+14.29%

Ms. Alyssa F. Varadhan

Independent Director

5.00K

+33.33%

Mr. Max Wygod

Executive Chairman of the Board, President, Chief Executive Officer

--

Mr. Michael T. (Mike) Vesey

Chief Financial Officer

--

Revenue Breakdown

Currency: USDUpdated: Sun, Apr 6

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

By BusinessUSD

Name

Revenue

Proportion

Healthcare Information

16.42M

58.62%

Software Subscriptions

9.77M

34.88%

Services

1.55M

5.52%

Other

274.26K

0.98%

No Data

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Healthcare Information

16.42M

58.62%

Software Subscriptions

9.77M

34.88%

Services

1.55M

5.52%

Other

274.26K

0.98%

Shareholding Stats

Updated: Sun, May 4

Shareholders

Shareholder Types

Shareholders

Proportion

Vuolo (Anthony)

12.91%

Wygod (Max C)

12.40%

Dublin (Adam H)

8.35%

The Adam H. Dublin 2019 Family Trust.

5.89%

Oracle Investment Management, Inc.

4.39%

Other

56.06%

Shareholders

Proportion

Vuolo (Anthony)

12.91%

Wygod (Max C)

12.40%

Dublin (Adam H)

8.35%

The Adam H. Dublin 2019 Family Trust.

5.89%

Oracle Investment Management, Inc.

4.39%

Other

56.06%

Shareholder Types

Shareholders

Proportion

Individual Investor

44.39%

Corporation

5.89%

Investment Advisor/Hedge Fund

5.29%

Hedge Fund

3.69%

Investment Advisor

3.59%

Family Office

0.28%

Research Firm

0.16%

Other

36.72%

Institutional Shareholding



Updated: Wed, Oct 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q3

53

3.96M

12.73%

-855.62K

2025Q2

71

21.65M

69.40%

+1.49M

2025Q1

76

23.31M

74.88%

+2.93M

2024Q4

76

20.36M

65.61%

+917.97K

2024Q3

74

19.39M

62.41%

-972.90K

2024Q2

84

20.11M

64.71%

+282.10K

2024Q1

116

19.57M

61.30%

-681.11K

2023Q4

115

19.23M

60.20%

-763.63K

2023Q3

116

19.22M

59.03%

-685.87K

2023Q2

117

19.20M

58.98%

-791.05K

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

Vuolo (Anthony)

4.02M

12.91%

--

Apr 25, 2025

Wygod (Max C)

4.36M

14.01%

+585.19K

+15.50%

Aug 25, 2025

Dublin (Adam H)

2.61M

8.35%

+200.00K

+8.31%

Jul 15, 2025

The Adam H. Dublin 2019 Family Trust.

1.83M

5.89%

--

Apr 25, 2025

Oracle Investment Management, Inc.

1.37M

4.39%

--

Jun 30, 2025

Staley Capital Advisers, Inc.

1.10M

3.53%

--

Jun 30, 2025

Coleman (Thomas Jason)

908.48K

2.92%

--

Dec 31, 2024

Bushnell (Emily)

901.22K

2.9%

+500.83K

+125.09%

Aug 25, 2025

The Vanguard Group, Inc.

775.14K

2.49%

--

Jun 30, 2025

Spaniel (Edward Francis JR)

688.97K

2.21%

-116.25K

-14.44%

Apr 25, 2025

Related ETFs



Updated: 9 hours ago

Name

Proportion

iShares Micro-Cap ETF

0.01%

Dimensional US Core Equity 1 ETF

0%

DFA Dimensional US Sustainability Core 1 ETF

0%

iShares Micro-Cap ETF

Proportion0.01%

Dimensional US Core Equity 1 ETF

Proportion0%

DFA Dimensional US Sustainability Core 1 ETF

Proportion0%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split



Date

Type

Ratio

No Data

Date

Type

Ratio

No Data